{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:40:09Z","timestamp":1749321609749,"version":"3.41.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1097\/iae.0000000000003265","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T13:03:52Z","timestamp":1626959032000},"page":"2007-2008","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Salivary Alpha-Amylase Levels May Correlate With Central Serous Chorioretinopathy Activity"],"prefix":"10.1097","volume":"41","author":[{"given":"Aliaa H.","family":"Abdelhakim","sequence":"first","affiliation":[{"name":"Vitreous Retina Macula Consultants of New York, New York"},{"name":"Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University Medical Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Ledesma-Gil","sequence":"additional","affiliation":[{"name":"Vitreous Retina Macula Consultants of New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence A.","family":"Yannuzzi","sequence":"additional","affiliation":[{"name":"Vitreous Retina Macula Consultants of New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0161-6420(02)01975-9","article-title":"Endocrine abnormalities in patients with central serous chorioretinopathy","volume":"110","author":"Haimovici","year":"2003","journal-title":"Ophthalmology"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids","volume":"47","author":"Bouzas","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"442","DOI":"10.5301\/ejo.5000790","article-title":"Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome","volume":"26","author":"van Dijk","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archopht.1993.01090090081024","article-title":"Central serous chorioretinopathy in endogenous hypercortisolism","volume":"111","author":"Bouzas","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00164568","article-title":"Six cases of central serous choroidopathy induced by systemic corticosteroid therapy","volume":"60","author":"Harada","year":"1985","journal-title":"Doc Ophthalmol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1097\/IAE.0000000000002333","article-title":"Genetic risk factors in acute central serous chorioretinopathy","volume":"39","author":"Mohabati","year":"2019","journal-title":"Retina"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00006982-200110000-00030","article-title":"Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or ecstasy","volume":"21","author":"Hassan","year":"2001","journal-title":"Retina"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","article-title":"Type-A behavior and central serous chorioretinopathy","volume":"7","author":"Yannuzzi","year":"1987","journal-title":"Retina"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","article-title":"Systemic findings associated with central serous chorioretinopathy, 1999 chorioretinopathy","volume":"128","author":"Tittl","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1176\/ajp.144.1.46","article-title":"Loss of vision due to central serous chorioretinopathy following psychological stress","volume":"144","author":"Gelber","year":"1987","journal-title":"Am J Psychiatry"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bjo.87.6.704","article-title":"Psychosomatic aspects in patients with central serous chorioretinopathy","volume":"87","author":"Spahn","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"De Kloet","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1167\/iovs.05-1246","article-title":"Sympathetic\u2013parasympathetic activity and reactivity in central serous chorioretinopathy: a case\u2013control study","volume":"47","author":"Tewari","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s004170050123","article-title":"Assessment of the sympatho-vagal interaction in central serous chorioretinopathy measured by power spectral analysis of heart rate variability","volume":"236","author":"Bernasconi","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1475-097X.1996.tb00731.x","article-title":"Salivary \u03b1\u2010amylase as a measure of endogenous adrenergic activity","volume":"16","author":"Chatterton","year":"1996","journal-title":"Clin Physiol Funct Imaging"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1196\/annals.1314.033","article-title":"Psychosocial stress\u2010induced activation of salivary alphaamylase: an indicator of sympathetic activity?","volume":"1032","author":"Rohleder","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.psyneuen.2009.01.014","article-title":"Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research","volume":"34","author":"Nater","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.psyneuen.2007.02.007","article-title":"Determinants of the diurnal course of salivary alpha-amylase","volume":"32","author":"Nater","year":"2007","journal-title":"Psychoneuroendocrinology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:02:01Z","timestamp":1749319321000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003265","relation":{},"ISSN":["0275-004X"],"issn-type":[{"type":"print","value":"0275-004X"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}